Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Restricted cash	$ 4,849,582	$ 2,993,011
Notes receivable	164,561,845	130,632,641
Deferred tax asset valuation allowance	3,741,900	32,450,807
Unamortized debt issuance costs, current		$ 619,094
Unamortized debt issuance costs, noncurrent	$ 1,008,441
Common stock par value (in usd per share)	$ 0.00001	$ 0.00001
Common stock authorized (in shares)	750,000,000	750,000,000
Common stock issued (in shares)	5,797,732	5,826,206
Common stock outstanding (in shares)	5,622,579	5,697,517
Treasury stock at cost (in shares)	175,153	128,689
Other payables	$ 7,455,416	$ 5,261,436
Variable Interest Entity, Primary Beneficiary
Restricted cash	4,095,855	2,868,011
Notes receivable	$ 152,174,296	$ 125,188,900